Skip to main content
SpringerLink
Log in

Erectile Dysfunction and Infertility

  • Chapter
  • First Online:
Men's Sexual Health and Fertility

  • 1585 Accesses

Abstract

Infertility and sexual dysfunction in men, specifically erectile dysfunction (ED), are distinct entities that share a complex and interdependent relationship with one another. This chapter discusses the similarities and differences between the etiologies and treatments for each condition and highlights the potential impact infertility may have on male sexual function. It is important to consider these as linked entities during evaluation of affected men and to structure treatment approaches while considering the numerous and varied causes of both ED and male infertility, given the close relationship between the two conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tietze C, Guttmacher AF, Rubin S. Time required for conception in 1727 planned pregnancies. Fertil Steril. 1950;1(4):338–46.

    CAS  PubMed  Google Scholar 

  2. Spira A. Epidemiology of human reproduction. Hum Reprod. 1986;1(2):111–5.

    CAS  PubMed  Google Scholar 

  3. Thonneau P, Marchand S, Tallec A, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod. 1991;6(6):811–6.

    CAS  PubMed  Google Scholar 

  4. Martinez GM, Chandra A, Abma JC, Jones J, Mosher WD. Fertility, contraception, and fatherhood: data on men and women from cycle 6 (2002) of the 2002 national survey of family growth. Vital Health Stat 23. 2006;26:1–142

    Google Scholar 

  5. Meacham RB, Joyce GF, Wise M, Kparker A, Niederberger C, Urologic Diseases in America Project. Male infertility. J Urol. 2007;177(6):2058–66. doi:10.1016/j.juro.2007.01.131.

    PubMed  Google Scholar 

  6. Marketdata Enterprises I. U.S. fertility clinics & infertility services: an industry analysis. http://www.marketresearch.com/Marketdata-Enterprises-Inc-v416/Fertility-Clinics-Infertility-Services-2403343/. Accessed 1 Aug 2009.

  7. Kolettis PN, Sabanegh ES. Significant medical pathology discovered during a male infertility evaluation. J Urol. 2001;166(1):178–80.

    CAS  PubMed  Google Scholar 

  8. Eisenberg ML, Park Y, Hollenbeck AR, Lipshultz LI, Schatzkin A, Pletcher MJ. Fatherhood and the risk of cardiovascular mortality in the NIH-AARP diet and health study. Hum Reprod. 2011;26(12):3479–85. doi:10.1093/humrep/der305.

    PubMed  Google Scholar 

  9. NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993;270(1):83–90.

    Google Scholar 

  10. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–30.

    CAS  PubMed  Google Scholar 

  11. Derogatis LR, Burnett AL. The epidemiology of sexual dysfunctions. J Sex Med. 2008;5(2):289–300. doi:10.1111/j.1743-6109.2007.00668.x.

    PubMed  Google Scholar 

  12. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50–6.

    CAS  PubMed  Google Scholar 

  13. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘cologne male survey’. Int J Impot Res. 2000;12(6):305–11. doi:10.1038/sj.ijir.3900622.

    CAS  PubMed  Google Scholar 

  14. Nicolosi A, Laumann EO, Glasser DB, et al. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology. 2004;64(5):991–7. doi:10.1016/j.urology.2004.06.055.

    PubMed  Google Scholar 

  15. Rosen RC, Fisher WA, Eardley I, et al. The multinational men’s attitudes to life events and sexuality (MALES) study: I. prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20(5):607–17.

    PubMed  Google Scholar 

  16. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ, Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207–12. doi:10.1001/archinte.166.2.207.

    PubMed  Google Scholar 

  17. Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey. J Sex Med. 2007;4(1):57–65. doi:10.1111/j.1743-6109.2006.00340.x.

    PubMed  Google Scholar 

  18. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151–7. doi:10.1016/j.amjmed.2006.06.010.

    PubMed  Google Scholar 

  19. Litwin MS, Saigal CS, Yano EM, et al. Urologic diseases in America project: analytical methods and principal findings. J Urol. 2005;173(3):933–7. doi:10.1097/01.ju.0000152365.43125.3b.

    PubMed  Google Scholar 

  20. Wessells H, Joyce GF, Wise M, Wilt TJ. Erectile dysfunction. J Urol. 2007;177(5):1675–81. doi:10.1016/j.juro.2007.01.057.

    PubMed  Google Scholar 

  21. Schouten BW, Bohnen AM, Groeneveld FP, Dohle GR, Thomas S, Bosch JL. Erectile dysfunction in the community: trends over time in incidence, prevalence, GP consultation and medication use—the Krimpen study: trends in ED. J Sex Med. 2010;7(7):2547–53. doi:10.1111/j.1743-6109.2010.01849.x.

    PubMed  Google Scholar 

  22. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. BMJ. 2000;321(7259):499–503.

    CAS  PubMed  Google Scholar 

  23. Seftel AD, Miner MM, Kloner RA, Althof SE. Office evaluation of male sexual dysfunction. Urol Clin North Am. 2007;34(4):463–82. doi:10.1016/j.ucl.2007.08.004.

    PubMed  Google Scholar 

  24. Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology. 1998;52(5):848–52.

    CAS  PubMed  Google Scholar 

  25. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med. 1998;60(4):458–65.

    CAS  PubMed  Google Scholar 

  26. Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol. 1994;140(11):1003–8.

    CAS  PubMed  Google Scholar 

  27. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med. 2000;30(4):328–38. doi:10.1006/pmed.2000.0643.

    CAS  PubMed  Google Scholar 

  28. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. A prospective study of risk factors for erectile dysfunction. J Urol. 2006;176(1):217–21. doi:10.1016/S0022-5347(06)00589-1.

    PubMed  Google Scholar 

  29. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54–61.

    CAS  PubMed  Google Scholar 

  30. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology. 2000;56(2):302–6.

    CAS  PubMed  Google Scholar 

  31. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978–84. doi:10.1001/jama.291.24.2978.

    CAS  PubMed  Google Scholar 

  32. Esposito K, Ciotola M, Giugliano F, et al. Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res. 2006;18(4):405–10. doi:10.1038/sj.ijir.3901447.

    CAS  PubMed  Google Scholar 

  33. Schrader SM, Breitenstein MJ, Lowe BD. Cutting off the nose to save the penis. J Sex Med. 2008;5(8):1932–40. doi:10.1111/j.1743-6109.2008.00867.x.

    PubMed  Google Scholar 

  34. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999;19(1):67–85.

    CAS  PubMed  Google Scholar 

  35. Nurnberg HG, Gelenberg A, Hargreave TB, Harrison WM, Siegel RL, Smith MD. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry. 2001;158(11):1926–8.

    CAS  PubMed  Google Scholar 

  36. Carson CC, Lue TF. Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int. 2005;96(3):257–80. doi:10.1111/j.1464-410X.2005.05614.x.

    CAS  PubMed  Google Scholar 

  37. Linet OI, Neff LL. Intracavernous prostaglandin E1 in erectile dysfunction. Clin Investig. 1994;72(2):139–49.

    CAS  PubMed  Google Scholar 

  38. Lakin MM, Montague DK, VanderBrug Medendorp S, Tesar L, Schover LR. Intracavernous injection therapy: analysis of results and complications. J Urol. 1990;143(6):1138–41.

    CAS  PubMed  Google Scholar 

  39. Hellstrom WJ, Bennett AH, Gesundheit N, et al. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil. Urology. 1996;48(6):851–6.

    CAS  PubMed  Google Scholar 

  40. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med. 1997;336(1):1–7.

    CAS  PubMed  Google Scholar 

  41. Guay AT, Perez JB, Velasquez E, Newton RA, Jacobson JP. Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection. Eur Urol. 2000;38(6):671–6. doi: 20360.

    CAS  PubMed  Google Scholar 

  42. Hellstrom WJ, Montague DK, Moncada I, et al. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010;7(1 Pt 2):501–23. doi:10.1111/j.1743-6109.2009.01626.x.

    PubMed  Google Scholar 

  43. Nagler HM. Varicocele. In: Lipshultz LI, editor. Infertility in the male. St. Louis: Mosby Year Book; 1997. p. 336–59.

    Google Scholar 

  44. Nieschlag E. Classification of andrological disorders. In: Nieschlag E, Behre H, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. 2nd ed. Berlin: Springer; 1997. p. 83–7.

    Google Scholar 

  45. de Kretser D. Male infertility. Lancet. 1997;349(9054):787–90. doi:10.1016/S0140-6736(96)08341-9.

    PubMed  Google Scholar 

  46. Badenoch DF, Waxman J, Boorman L, et al. Administration of a gonadotropin releasing hormone analogue in oligozoospermic infertile males. Acta Endocrinol (Copenh). 1988;117(2):265–7.

    CAS  Google Scholar 

  47. Crottaz B, Senn A, Reymond MJ, Rey F, Germond M, Gomez F. Follicle-stimulating hormone bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: double-blind trial with gonadotropin-releasing hormone. Fertil Steril. 1992;57(5):1034–43.

    CAS  PubMed  Google Scholar 

  48. Attia AM, Al-Inany HG, Proctor ML. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev. 2006(1):CD005071. doi:10.1002/14651858.CD005071.pub2.

  49. Ashkenazi J, Bar-Hava I, Farhi J, et al. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril. 1999;72(4):670–3.

    CAS  PubMed  Google Scholar 

  50. Baccetti B, Piomboni P, Bruni E, et al. Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. Asian J Androl. 2004;6(2):133–7.

    CAS  PubMed  Google Scholar 

  51. Micic S, Dotlic R. Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men. J Urol. 1985;133(2):221–2.

    CAS  PubMed  Google Scholar 

  52. Liu PY, Handelsman DJ. The present and future state of hormonal treatment for male infertility. Hum Reprod Update. 2003;9(1):9–23.

    CAS  PubMed  Google Scholar 

  53. Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol. 2001;165(3):837–41.

    CAS  PubMed  Google Scholar 

  54. Clark RV, Sherins RJ. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. results of a double-blinded, randomized, placebo-controlled trial with crossover. J Androl. 1989;10(3):240–7.

    CAS  PubMed  Google Scholar 

  55. Suleiman SA, Ali ME, Zaki ZM, el-Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996;17(5):530–7.

    CAS  PubMed  Google Scholar 

  56. Rolf C, Cooper TG, Yeung CH, Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod. 1999;14(4):1028–33.

    CAS  PubMed  Google Scholar 

  57. Keskes-Ammar L, Feki-Chakroun N, Rebai T, et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl. 2003;49(2):83–94.

    CAS  PubMed  Google Scholar 

  58. Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005;84(3):662–71. doi:10.1016/j.fertnstert.2005.03.064.

    CAS  PubMed  Google Scholar 

  59. Sigman M, Glass S, Campagnone J, Pryor JL. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril. 2006;85(5):1409–14. doi:10.1016/j.fertnstert.2005.10.055.

    PubMed  Google Scholar 

  60. Cohlen BJ. Should we continue performing intrauterine inseminations in the year 2004? Gynecol Obstet Invest. 2005;59(1):3–13. doi:10.1159/000080492.

    CAS  PubMed  Google Scholar 

  61. Palermo GD, Neri QV, Takeuchi T, Rosenwaks Z. ICSI: where we have been and where we are going. Semin Reprod Med. 2009;27(2):191–201. doi:10.1055/s-0029-1202309.

    PubMed  Google Scholar 

  62. Hwang K, Yatsenko AN, Jorgez CJ, et al. Mendelian genetics of male infertility. Ann N Y Acad Sci. 2010;1214(1):E1–17. doi:10.1111/j.1749-6632.2010.05917.x.

    PubMed Central  PubMed  Google Scholar 

  63. Lue TF. Erectile dysfunction. N Engl J Med. 2000;342(24):1802–13. doi:10.1056/NEJM200006153422407.

    CAS  PubMed  Google Scholar 

  64. Hwang K, Walters RC, Lipshultz LI. Contemporary concepts in the evaluation and management of male infertility. Nat Rev Urol. 2011;8(2):86–94. doi:10.1038/nrurol.2010.230.

    CAS  PubMed Central  PubMed  Google Scholar 

  65. Mulligan T, Schmitt B. Testosterone for erectile failure. J Gen Intern Med. 1993;8(9):517–21.

    CAS  PubMed  Google Scholar 

  66. Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241–7. doi:10.1210/jc.2007-1245.

    CAS  PubMed  Google Scholar 

  67. Pfeifer S, Fritz M, Goldberg J, et al. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril. 2012;98(2):294–301. doi: 10.1016/j.fertnstert.2012.05.033.

    Google Scholar 

  68. Slag MF, Morley JE, Elson MK, et al. Impotence in medical clinic outpatients. JAMA. 1983;249(13):1736–40.

    CAS  PubMed  Google Scholar 

  69. Spark RF, White RA, Connolly PB. Impotence is not always psychogenic. Newer insights into hypothalamic-pituitary-gonadal dysfunction. JAMA. 1980;243(8):750–5.

    CAS  PubMed  Google Scholar 

  70. Buvat J, Lemaire A. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol. 1997;158(5):1764–7.

    CAS  PubMed  Google Scholar 

  71. Earle CM, Stuckey BG. Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy? Urology. 2003;62(4):727–31.

    PubMed  Google Scholar 

  72. Kelly TM, Edwards CQ, Meikle AW, Kushner JP. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med. 1984;101(5):629–32.

    CAS  PubMed  Google Scholar 

  73. Walton C, Kelly WF, Laing I, Bu’lock DE. Endocrine abnormalities in idiopathic haemochromatosis. Q J Med. 1983;52(205):99–110.

    CAS  PubMed  Google Scholar 

  74. Schwanzel-Fukuda M, Bick D, Pfaff DW. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res. 1989;6(4):311–26.

    CAS  PubMed  Google Scholar 

  75. Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG. Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med. 1978;299(16):847–52. doi:10.1056/NEJM197810192991602.

    CAS  PubMed  Google Scholar 

  76. Segal S, Yaffe H, Laufer N, Ben-David M. Male hyperprolactinemia: effects on fertility. Fertil Steril. 1979;32(5):556–61.

    CAS  PubMed  Google Scholar 

  77. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–88. doi:10.1210/jc.2010-1692.

    CAS  PubMed  Google Scholar 

  78. Velazquez EM, Bellabarba Arata G. Effects of thyroid status on pituitary gonadotropin and testicular reserve in men. Arch Androl. 1997;38(1):85–92.

    CAS  PubMed  Google Scholar 

  79. Abalovich M, Levalle O, Hermes R, et al. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males. Thyroid. 1999;9(9):857–63.

    CAS  PubMed  Google Scholar 

  80. Krassas GE, Pontikides N, Deligianni V, Miras K. A prospective controlled study of the impact of hyperthyroidism on reproductive function in males. J Clin Endocrinol Metab. 2002;87(8):3667–71.

    CAS  PubMed  Google Scholar 

  81. Corona G, Wu FCW, Forti G, et al. Thyroid hormones and male sexual function. Int J Androl. 2012;35(5):668–79. doi:10.1111/j.1365-2605.2012.01266.x.

    CAS  PubMed  Google Scholar 

  82. Maggi M, Buvat J, Corona G, Guay A, Torres LO. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J Sex Med. 2012. doi:10.1111/j.1743-6109.2012.02735.x.

  83. Hendry WF. Iatrogenic damage to male reproductive function. J R Soc Med. 1995;88(10):P579–84.

    Google Scholar 

  84. Kedia KR, Markland C, Fraley EE. Sexual function after high retroperitoneal lymphadenectomy. Urol Clin North Am. 1977;4(3):523–8.

    CAS  PubMed  Google Scholar 

  85. Nijman JM, Schraffordt Koops H, Oldhoff J, Kremer J, Sleijfer DT. Sexual function after surgery and combination chemotherapy in men with disseminated nonseminomatous testicular cancer. J Surg Oncol. 1988;38(3):182–6.

    CAS  PubMed  Google Scholar 

  86. Schover LR. Sexuality and fertility in urologic cancer patients. Cancer. 1987;60(3 Suppl):553–8.

    CAS  PubMed  Google Scholar 

  87. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 2002;167(2 Pt 2):1005–10.

    PubMed  Google Scholar 

  88. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol. 1991;145(5):998–1002.

    CAS  PubMed  Google Scholar 

  89. Borchers H, Brehmer B, Kirschner-Hermanns R, Reineke T, Tietze L, Jakse G. Erectile function after non-nerve-sparing radical prostatectomy: fact or fiction? Urol Int. 2006;76(3):213–6. doi:10.1159/000091621.

    PubMed  Google Scholar 

  90. Weinstein M, Roberts M. Sexual potency following surgery for rectal carcinoma. A follow-up of 44 patients. Ann Surg. 1977;185(3):295–300.

    CAS  PubMed  Google Scholar 

  91. Catalona WJ, Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol. 1990;143(3):538–43. discussion 544.

    CAS  PubMed  Google Scholar 

  92. Liang JT, Lai HS, Lee PH, Chang KJ. Laparoscopic pelvic autonomic nerve-preserving surgery for sigmoid colon cancer. Ann Surg Oncol. 2008;15(6):1609–16. doi:10.1245/s10434-008-9861-x.

    PubMed Central  PubMed  Google Scholar 

  93. Schoenberg MP, Walsh PC, Breazeale DR, Marshall FF, Mostwin JL, Brendler CB. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year follow-up. J Urol. 1996;155(2):490–4.

    CAS  PubMed  Google Scholar 

  94. Sica DA. Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev. 2005;10(1):23–9. doi:10.1007/s10741-005-2345-1.

    CAS  PubMed  Google Scholar 

  95. Griffin JE, Wilson JD. Disorders of the testes and male reproductive tract. In: Wilson JD, editor. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders; 2003. p. 709–69.

    Google Scholar 

  96. Harrison WM, Rabkin JG, Ehrhardt AA, et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol. 1986;6(3):144–9.

    CAS  PubMed  Google Scholar 

  97. Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br J Psychiatry. 1987;151:107–12.

    CAS  PubMed  Google Scholar 

  98. Keltner NL, McAfee KM, Taylor CL. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care. 2002;38(3):111–6.

    PubMed  Google Scholar 

  99. Sullivan G, Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hosp Community Psychiatry. 1990;41(11):1238–41.

    CAS  PubMed  Google Scholar 

  100. Nudell DM, Monoski MM, Lipshultz LI. Common medications and drugs: how they affect male fertility. Urol Clin North Am. 2002;29(4):965–73.

    PubMed  Google Scholar 

  101. Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int. 2006;97 Suppl 2:34–8. doi:10.1111/j.1464-410X.2006.06104.x. discussion 44–5.

    PubMed  Google Scholar 

  102. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med. 2011;8(3):872–84. doi:10.1111/j.1743-6109.2010.02157.x.

    CAS  PubMed  Google Scholar 

  103. Roehrborn CG, Siami P, Barkin J, et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol. 2008;179(2):616–21. doi:10.1016/j.juro.2007.09.084. discussion 621.

    CAS  PubMed  Google Scholar 

  104. Amory JK, Anawalt BD, Matsumoto AM, et al. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men. J Urol. 2008;179(6):2333–8. doi:10.1016/j.juro.2008.01.145.

    CAS  PubMed Central  PubMed  Google Scholar 

  105. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003;170(2 Pt 1):530–47. doi:10.1097/01.ju.0000078083.38675.79.

    Google Scholar 

  106. Marberger M, Roehrborn CG, Marks LS, Wilson T, Rittmaster RS. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91(4):1323–8. doi:10.1210/jc.2005-1947.

    CAS  PubMed  Google Scholar 

  107. Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2012. doi:10.1016/j.juro.2012.09.043.

  108. Zacharin M, Sabin MA, Nair VV, Dagabdhao P. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril. 2012;98(4):836–42. doi:10.1016/j.fertnstert.2012.06.022.

    CAS  PubMed  Google Scholar 

  109. Wischmann T, Stammer H, Scherg H, Gerhard I, Verres R. Psychosocial characteristics of infertile couples: a study by the ‘Heidelberg fertility consultation service’. Hum Reprod. 2001;16(8):1753–61.

    CAS  PubMed  Google Scholar 

  110. Kedem P, Mikulincer M, Nathanson YE, Bartoov B. Psychological aspects of male infertility. Br J Med Psychol. 1990;63(Pt 1):73–80.

    PubMed  Google Scholar 

  111. Shindel AW, Nelson CJ, Naughton CK, Ohebshalom M, Mulhall JP. Sexual function and quality of life in the male partner of infertile couples: prevalence and correlates of dysfunction. J Urol. 2008;179(3):1056–9. doi:10.1016/j.juro.2007.10.069.

    PubMed  Google Scholar 

  112. Monga M, Alexandrescu B, Katz SE, Stein M, Ganiats T. Impact of infertility on quality of life, marital adjustment, and sexual function. Urology. 2004;63(1):126–30.

    PubMed  Google Scholar 

  113. Jain K, Radhakrishnan G, Agrawal P. Infertility and psychosexual disorders: relationship in infertile couples. Indian J Med Sci. 2000;54(1):1–7.

    CAS  PubMed  Google Scholar 

  114. Benazon N, Wright J, Sabourin S. Stress, sexual satisfaction, and marital adjustment in infertile couples. J Sex Marital Ther. 1992;18(4):273–84. doi:10.1080/00926239208412852.

    CAS  PubMed  Google Scholar 

  115. Slade P, Raval H, Buck P, Lieberman BE. A 3-year follow-up of emotional, marital and sexual functioning in couples who were infertile. J Reprod Inf Psychol. 1992;10(4):233–43. doi:10.1080/02646839208403956.

    Google Scholar 

  116. O’Brien JH, Lazarou S, Deane L, Jarvi K, Zini A. Erectile dysfunction and andropause symptoms in infertile men. J Urol. 2005;174(5):1932–4. doi:10.1097/01.ju.0000177453.14334.a2. discussion 1934.

    PubMed  Google Scholar 

  117. Mahlstedt PP. The psychological component of infertility. Fertil Steril. 1985;43(3):335–46.

    CAS  PubMed  Google Scholar 

  118. Glover L, Gannon K, Sherr L, Abel PD. Psychological distress before and immediately after attendance at a male sub-fertility clinic. J R Soc Med. 1994;87(8):448–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  119. Keye Jr WR. Psychosexual responses to infertility. Clin Obstet Gynecol. 1984;27(3):760–6.

    PubMed  Google Scholar 

  120. Sigg C. Sexuality and sterility. Ther Umsch. 1994;51(2):115–9.

    CAS  PubMed  Google Scholar 

  121. Gurkan L, Raynor MC, Hellstrom WJ. Sex and the infertile male. Semin Reprod Med. 2009;27(2):186–90. doi:10.1055/s-0029-1202308.

    PubMed  Google Scholar 

  122. Saleh RA, Ranga GM, Raina R, Nelson DR, Agarwal A. Sexual dysfunction in men undergoing infertility evaluation: a cohort observational study. Fertil Steril. 2003;79(4):909–12.

    PubMed  Google Scholar 

  123. Nachtigall RD, Becker G, Wozny M. The effects of gender-specific diagnosis on men’s and women’s response to infertility. Fertil Steril. 1992;57(1):113–21.

    CAS  PubMed  Google Scholar 

  124. Drake TS, Grunert GM. A cyclic pattern of sexual dysfunction in the infertility investigation. Fertil Steril. 1979;32(5):542–5.

    CAS  PubMed  Google Scholar 

  125. Burns LH. Psychiatric aspects of infertility and infertility treatments. Psychiatr Clin North Am. 2007;30(4):689–716. doi:10.1016/j.psc.2007.08.001.

    PubMed  Google Scholar 

  126. Lue TF. Impotence: a patient’s goal-directed approach to treatment. World J Urol. 1990;8(2):67–74.

    Google Scholar 

  127. Lue TF. A patient’s goal-directed approach to erectile dysfunction and Peyronie’s disease. Can J Urol. 1995;2(Supp 1):13–7.

    PubMed  Google Scholar 

  128. Hatzichristou D, Rosen RC, Broderick G, et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med. 2004;1(1):49–57. doi:10.1111/j.1743-6109.2004.10108.x.

    PubMed  Google Scholar 

  129. Hatzichristou D, Rosen RC, Derogatis LR, et al. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med. 2010;7(1 pt 2):337–48. doi:10.1111/j.1743-6109.2009.01619.x.

    PubMed  Google Scholar 

  130. Jarow JP, Nana-Sinkam P, Sabbagh M, Eskew A. Outcome analysis of goal directed therapy for impotence. J Urol. 1996;155(5):1609–12.

    CAS  PubMed  Google Scholar 

  131. Hanash KA. Comparative results of goal oriented therapy for erectile dysfunction. J Urol. 1997;157(6):2135–8.

    CAS  PubMed  Google Scholar 

  132. Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R. Recommendations of the international scientific committee on the evaluation and treatment of erectile dysfunction. 2000.

    Google Scholar 

  133. Lue TF, Giuliano F, Montorsi F, et al. Original research: summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1(1):6–23. doi:10.1111/j.1743-6109.2004.10104.x.

    PubMed  Google Scholar 

  134. Montorsi F, Adaikan G, Becher E, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572–88. doi:10.1111/j.1743-6109.2010.02062.x.

    PubMed  Google Scholar 

  135. Lewis JM, Osbourne AL, O’Leary MP. Erectile dysfunction. J Med Liban. 2004;52(4):213–6.

    PubMed  Google Scholar 

  136. Nusbaum MR, Hamilton CD. The proactive sexual health history. Am Fam Physician. 2002;66(9):1705–12.

    PubMed  Google Scholar 

  137. Burnett AL. Erectile dysfunction: a practical approach for primary care. Geriatrics. 1998;53(2):34. http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=1998040346&site=ehost-live.

    Google Scholar 

  138. Davis-Joseph B, Tiefer L, Melman A. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology. 1995;45(3):498–502.

    CAS  PubMed  Google Scholar 

  139. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the epidemiologia de la disfuncion erectil masculina study. J Urol. 2001;166(2):569–74. discussion 574–5.

    CAS  PubMed  Google Scholar 

  140. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96((12, Supplement 2)):85–93. doi:10.1016/j.amjcard.2005.12.018.

    Google Scholar 

  141. Kingsberg SA. Taking a sexual history. Obstet Gynecol Clin North Am. 2006;33(4):535–47. doi:10.1016/j.ogc.2006.09.002.

    PubMed  Google Scholar 

  142. Fisher WA, Eardley I, McCabe M, Sand M. Original research? Couples’ sexual Dysfunctions: erectile dysfunction (ED) is a shared sexual concern of couples I: couple conceptions of ED. J Sex Med. 2009;6(10):2746–60. doi:10.1111/j.1743-6109.2009.01457.x.

    PubMed  Google Scholar 

  143. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319–26.

    CAS  PubMed  Google Scholar 

  144. Sun P, Swindle R. Are men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction? A naturalistic national cohort study. J Urol. 2005;174(1):244–8. doi:10.1097/01.ju.0000162050.84946.86.

    PubMed  Google Scholar 

  145. Zonszein J. Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am. 1995;22(4):789–802.

    CAS  PubMed  Google Scholar 

  146. Ghanem HM, Salonia A, Martin-Morales A. Physical examination and laboratory testing for men with ED. J Sex Med. 2012. doi:10.1111/j.1743-6109.2012.02671.x

  147. Ghanem HM, Salonia A, Martin-Morales A. SOP: physical examination and laboratory testing for men with erectile dysfunction. J Sex Med. 2013;10(1):108–10. doi:10.1111/j.1743-6109.2012.02734.x.

    PubMed  Google Scholar 

  148. Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the look AHEAD trial. J Sex Med. 2010;7(1 Pt 1):156–65. doi:10.1111/j.1743-6109.2009.01458.x.

    PubMed  Google Scholar 

  149. Lamina S, Okoye CG, Dagogo TT. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients. J Clin Hypertens (Greenwich). 2009;11(3):125–9. doi:10.1111/j.1751-7176.2009.00086.x.

    Google Scholar 

  150. Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797–803. doi:10.1001/archinternmed.2011.440.

    PubMed  Google Scholar 

  151. Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: the management of erectile dysfunction: an AUA update. J Urol. 2005;174(1):230–9. doi:10.1097/01.ju.0000164463.19239.19.

    PubMed  Google Scholar 

  152. Esposito K, Giugliano D. Lifestyle for erectile dysfunction: a good choice. Arch Intern Med. 2012;172(3):295–6. doi:10.1001/archinternmed.2011.785. author reply 296.

    PubMed  Google Scholar 

  153. Shabsigh R, Donatucci C, Costabile R, et al. Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success. Int J Impot Res. 2010;22(1):1–8. doi:10.1038/ijir.2009.29.

    CAS  PubMed  Google Scholar 

  154. Montorsi F, Padma-Nathan H, Buvat J, et al. Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial. J Sex Med. 2004;1(2):168–78. doi:10.1111/j.1743-6109.2004.04025.x.

    CAS  PubMed  Google Scholar 

  155. Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ, Deriesthal H. Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial. Urology. 2003;62(3):400–3.

    CAS  PubMed  Google Scholar 

  156. Carson CC. Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education. Int J Impot Res. 2002;14 Suppl 1:S29–34. doi:10.1038/sj.ijir.3900804.

    PubMed  Google Scholar 

  157. Rajagopalan P, Mazzu A, Xia C, Dawkins R, Sundaresan P. Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction. J Clin Pharmacol. 2003;43(3):260–7.

    CAS  PubMed  Google Scholar 

  158. Wespes E, Amar E, Hatzichristou D, et al. EAU guidelines on erectile dysfunction: an update. Eur Urol. 2006;49(5):806–15. doi:10.1016/j.eururo.2006.01.028.

    PubMed  Google Scholar 

  159. Fulgham PF, Cochran JS, Denman JL, et al. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol. 1998;160(6 Pt 1):2041–6.

    CAS  PubMed  Google Scholar 

  160. Mulhall JP, Jahoda AE, Ahmed A, Parker M. Analysis of the consistency of intraurethral prostaglandin E(1) (MUSE) during at-home use. Urology. 2001;58(2):262–6.

    CAS  PubMed  Google Scholar 

  161. Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res. 2002;14 Suppl 1:S38–42. doi:10.1038/sj.ijir.3900795.

    PubMed  Google Scholar 

  162. Mydlo JH, Volpe MA, MacChia RJ. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. BJU Int. 2000;86(4):469–73.

    CAS  PubMed  Google Scholar 

  163. Lewis RW. Intraurethral and topical agents. Drugs Today (Barc). 2000;36(2–3):113–9.

    CAS  Google Scholar 

  164. Costa P, Potempa AJ. Intraurethral alprostadil for erectile dysfunction: a review of the literature. Drugs. 2012;72(17):2243–54. doi:10.2165/11641380-000000000-00000.

    CAS  PubMed  Google Scholar 

  165. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med. 1996;334(14):873–7. doi:10.1056/NEJM199604043341401.

    CAS  PubMed  Google Scholar 

  166. Heaton JP, Lording D, Liu SN, et al. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Int J Impot Res. 2001;13(6):317–21.

    CAS  PubMed  Google Scholar 

  167. Sidi AA, Cameron JS, Duffy LM, Lange PH. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. J Urol. 1986;135(4):704–6.

    CAS  PubMed  Google Scholar 

  168. Zorgniotti AW, Lefleur RS. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol. 1985;133(1):39–41.

    CAS  PubMed  Google Scholar 

  169. Robinette MA, Moffat MJ. Intracorporal injection of papaverine and phentolamine in the management of impotence. Br J Urol. 1986;58(6):692–5.

    CAS  PubMed  Google Scholar 

  170. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol. 1996;155(3):802–15.

    CAS  PubMed  Google Scholar 

  171. Bennett AH, Carpenter AJ, Barada JH. An improved vasoactive drug combination for a pharmacological erection program. J Urol. 1991;146(6):1564–5.

    CAS  PubMed  Google Scholar 

  172. Moemen MN, Hamed HA, Kamel II, Shamloul RM, Ghanem HM. Clinical and sonographic assessment of the side effects of intracavernous injection of vasoactive substances. Int J Impot Res. 2004;16(2):143–5. doi:10.1038/sj.ijir.3901194.

    CAS  PubMed  Google Scholar 

  173. Hackett G, Kell P, Ralph D, et al. British society for sexual medicine guidelines on the management of erectile dysfunction. J Sex Med. 2008;5(8):1841–65. doi:10.1111/j.1743-6109.2008.00773.x.

    PubMed  Google Scholar 

  174. Broderick GA, McGahan JP, Stone AR, White RD. The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound. J Urol. 1992;147(1):57–61.

    CAS  PubMed  Google Scholar 

  175. McMahon CG. Nonsurgical treatment of cavernosal venous leakage. Urology. 1997;49(1):97–100. doi:10.1016/S0090-4295(96)00389-5.

    CAS  PubMed  Google Scholar 

  176. Witherington R. Vacuum constriction device for management of erectile impotence. J Urol. 1989;141(2):320–2.

    CAS  PubMed  Google Scholar 

  177. Sidi AA, Becher EF, Zhang G, Lewis JH. Patient acceptance of and satisfaction with an external negative pressure device for impotence. J Urol. 1990;144(5):1154–6.

    CAS  PubMed  Google Scholar 

  178. Nadig PW, Ware JC, Blumoff R. Noninvasive device to produce and maintain an erection-like state. Urology. 1986;27(2):126–31.

    CAS  PubMed  Google Scholar 

  179. Vrijhof HJ, Delaere KP. Vacuum constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed aetiology. Br J Urol. 1994;74(1):102–5.

    CAS  PubMed  Google Scholar 

  180. Dutta TC, Eid JF. Vacuum constriction devices for erectile dysfunction: a long-term, prospective study of patients with mild, moderate, and severe dysfunction. Urology. 1999;54(5):891–3.

    CAS  PubMed  Google Scholar 

  181. Blackard CE, Borkon WD, Lima JS, Nelson J. Use of vacuum tumescence device for impotence secondary to venous leakage. Urology. 1993;41(3):225–30.

    CAS  PubMed  Google Scholar 

  182. Baltaci S, Aydos K, Kosar A, Anafarta K. Treating erectile dysfunction with a vacuum tumescence device: a retrospective analysis of acceptance and satisfaction. Br J Urol. 1995;76(6):757–60.

    CAS  PubMed  Google Scholar 

  183. Turner LA, Althof SE, Levine SB, et al. Treating erectile dysfunction with external vacuum devices: impact upon sexual, psychological and marital functioning. J Urol. 1990;144(1):79–82.

    CAS  PubMed  Google Scholar 

  184. Turner LA, Althof SE, Levine SB, Bodner DR, Kursh ED, Resnick MI. External vacuum devices in the treatment of erectile dysfunction: a one-year study of sexual and psychosocial impact. J Sex Marital Ther. 1991;17(2):81–93. doi:10.1080/00926239108404950.

    CAS  PubMed  Google Scholar 

  185. Cookson MS, Nadig PW. Long-term results with vacuum constriction device. J Urol. 1993;149(2):290–4.

    CAS  PubMed  Google Scholar 

  186. Montague DK, Angermeier KW. Penile prosthesis implantation. Urol Clin North Am. 2001;28(2):355–61. x.

    CAS  PubMed  Google Scholar 

  187. Montague DK, Angermeier KW. Contemporary aspects of penile prosthesis implantation. Urol Int. 2003;70(2):141–6. doi: 68189.

    PubMed  Google Scholar 

  188. Lotti F, Corona G, Rastrelli G, Forti G, Jannini EA, Maggi M. Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility. J Sex Med. 2012;9(10):2698–707. doi:10.1111/j.1743-6109.2012.02872.x.

    PubMed  Google Scholar 

  189. Rosen RC. Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am. 2001;28(2):269–78.

    CAS  PubMed  Google Scholar 

  190. McCabe M, Althof SE, Assalian P, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med. 2010;7(1 Pt 2):327–36. doi:10.1111/j.1743-6109.2009.01618.x.

    PubMed  Google Scholar 

  191. Wylie KR. Treatment outcome of brief couple therapy in psychogenic male erectile disorder. Arch Sex Behav. 1997;26(5):527–45.

    CAS  PubMed  Google Scholar 

  192. Hawton K. Integration of treatments for male erectile dysfunction. Lancet. 1998;351(9095):7–8. doi:10.1016/S0140-6736(05)78097-1.

    CAS  PubMed  Google Scholar 

  193. Hellstrom WJ, Wang R, Peterson CA, Varady JC, Gesundheit N, Sikka SC. Effects of alprostadil and prazosin on motility, viability and membrane integrity of human sperm. J Urol. 1998;159(5):1559–62. doi:10.1097/00005392-199805000-00041.

    CAS  PubMed  Google Scholar 

  194. Kobayashi K, Masumori N, Hisasue S, et al. Inhibition of seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers. J Sex Med. 2008;5(9):2185–90. doi:10.1111/j.1743-6109.2008.00779.x.

    PubMed  Google Scholar 

  195. Andrade JR, Traboulsi A, Hussain A, Dubin NH. In vitro effects of sildenafil and phentolamine, drugs used for erectile dysfunction, on human sperm motility. Am J Obstet Gynecol. 2000;182(5):1093–5.

    CAS  PubMed  Google Scholar 

  196. Tillem SM, Mellinger BC. Azoospermia due to aperistalsis of the vas deferens: successful treatment with pseudoephedrine. Urology. 1999;53(2):417–9.

    CAS  PubMed  Google Scholar 

  197. Smith JF, Walsh TJ, Turek PJ. Ejaculatory duct obstruction. Urol Clin North Am. 2008;35(2):221–7. doi:10.1016/j.ucl.2008.01.011. viii.

    PubMed  Google Scholar 

  198. Jones Jr HW, Jones GS, Andrews MC, et al. The program for in vitro fertilization at Norfolk. Fertil Steril. 1982;38(1):14–21.

    PubMed  Google Scholar 

Download references

Financial Support

None.

Author information

Authors and Affiliations

  1. Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA

    Vikram Soni & Alexander W. Pastuszak

  2. Scott Department of Urology, Baylor College of Medicine, 6620 Main St, Suite 1325, Houston, TX, USA

    Mohit Khera

Authors
  1. Vikram Soni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander W. Pastuszak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohit Khera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohit Khera .

Editor information

Editors and Affiliations

  1. Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    John P. Mulhall

  2. Department of Urology, Kaiser Permanente, Oakland Medical Center, Oakland, California, USA

    Wayland Hsiao

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Soni, V., Pastuszak, A.W., Khera, M. (2014). Erectile Dysfunction and Infertility. In: Mulhall, J., Hsiao, W. (eds) Men's Sexual Health and Fertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0425-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0425-9_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0424-2

  • Online ISBN: 978-1-4939-0425-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation